InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,650.59
(
0.34%
)
US TECH 100
19,769.20
(
-0.39%
)
Dow Jones
40,800.72
(
1.46%
)
Brent Oil
83.38
(
-1.14%
)
Bitcoin
64,433.99
(
-0.64%
)
Post# of 252610
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120054
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 197247

Monday, 11/16/2015 11:21:45 AM

Monday, November 16, 2015 11:21:45 AM

Post# of 252610
Today's ABBV/ENTA-vs-MRK data not apples-to-apples:

In the data reported today, all of MRK’s patients were treatment-naïve, while 10% of the ABBV/ENTA's patients in the highest-dose GT3 cohort were treatment-experienced.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up